A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhi, Feng ^a   Shao, Naiyuan ^a   Li, Bowen ^a   Xue, Lian ^a   Deng, Danni ^a   Xu, Yuan ^a   Lan, Qing ^b   Peng, Ya ^a   Yang, Yilin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN224 MICRORNA, HUMAN; MIRN409 MICRORNA, HUMAN;

BLOOD; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; HUMAN; MALE; MENINGIOMA; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84984685559     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32067     Document Type: Article

References (34)

1. Louis, D. N. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97-109 (2007)
2. Modha, A. & Gutin, P. H. Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57, 538-550, discussion 538-550 (2005)
3. Mawrin, C. & Perry, A. Pathological classification and molecular genetics of meningiomas. J Neurooncol 99, 379-391 (2010)
4. Whittle, I. R., Smith, C., Navoo, P. & Collie, D. Meningiomas. Lancet 363, 1535-1543 (2004)
5. Simpson, D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20, 22-39 (1957)
6. He, S. et al. A review of epigenetic and gene expression alterations associated with intracranial meningiomas. Neurosurg Focus 35, E5 (2013)
7. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004)
8. He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531 (2004)
9. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004)
10. Esquela-Kerscher, A. & Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269 (2006)
11. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866 (2006)
12. Ryan, B. M., Robles, A. I. & Harris, C. C. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10, 389-402 (2010)
13. Zhi, F. et al. A microRNA expression signature predicts meningioma recurrence. Int J Cancer 132, 128-136 (2013)
14. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997-1006 (2008)
15. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513-10518 (2008)
16. Zhi, F. et al. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol 17, 383-391 (2015)
17. Sohn, W. et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Experimental & molecular medicine 47, e184 (2015)
18. Murray, M. J. et al. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer 114, 151-162 (2016)
19. Zhang, Y. et al. Serum miRNAs panel (miR-16-2∗, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Sci Rep 5, 17942 (2015)
20. Lawrie, C. H. et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141, 672-675 (2008)
21. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9, 654-659 (2007)
22. Tang, H. et al. Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma. J Cancer Res Ther 11, 630-634 (2015)
23. Wang, Q. et al. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res 31, 97 (2012)
24. Zen, K. & Zhang, C. Y. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32, 326-348 (2012)
25. Weber, J. A. et al. The microRNA spectrum in 12 body fluids. Clin Chem 56, 1733-1741 (2010)
26. Redova, M., Sana, J. & Slaby, O. Circulating miRNAs as new blood-based biomarkers for solid cancers. Future Oncology 9, 387-402 (2013)
27. Weickmann, J. L. & Glitz, D. G. Human ribonucleases. Quantitation of pancreatic-like enzymes in serum, urine, and organ preparations. J Biol Chem 257, 8705-8710 (1982)
28. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13, 423-433 (2011)
29. Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414 (2007)
30. Wang, M. et al. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma. Biochem Biophys Res Commun 460, 354-361 (2015)
31. Kliese, N. et al. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene 32, 4712-4720 (2013)
32. Saydam, O. et al. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol 29, 5923-5940 (2009)
33. Senol, O. et al. miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo. Oncogene 34, 1790-1798 (2015)
34. Shi, L. et al. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. J Neurooncol 110, 155-162 (2012)